2021 Emerging Topics in Liver Disease

2021 Emerging Topics in Liver Disease is organized by Houston Methodist and will be held on Aug 28, 2021.

Target Audience:
This conference is designed for primary care physicians, internists, hepatologists, gastroenterologists, oncologists, nurses, nurse Practitioners and physician assistants.

CME Accreditation:
Physicians:
Houston Methodist designates this live activity for a maximum of 8.5 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with their participation in the activity.

Nurses:
Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Houston Methodist will provide 8.66 Continuing Nursing Education contact hours for this activity. Participants must attend the activity in its entirety and complete the continuing nursing education evaluation.

Social Workers:
Houston Methodist and The J.C. Walter Jr. Transplant Center designate this activity for 8.0 CEUs for social work

Description:
The epidemic of liver disease has become increasingly more common and poses complex problems in their diagnosis and management. This CME activity has been designed to provide attendees with relevant information regarding new developments in hepatology and new approaches to management of liver diseases that can be readily be integrated into their daily practice.  A group of national experts, including several renowned guest faculty will present new findings in a clinical context that will be beneficial in the multidisciplinary management of unique and complex liver disorders. There are recent advances in the diagnosis and management of patients with liver disease for Primary Care Physicians, Gastroenterologists, nurses, nurse practitioners, physician assistants and other health care providers.  

Objectives Topics:
At the conclusion of this activity, the participant should be able to: 
• Explain the current diagnosis and management of complications of portal hypertension and metabolic liver diseases.
• Identify emerging trends in fatty liver disease and determine the latest concepts in diagnosis and management.
• Provide significant information regarding new and critical developments in chronic HBV, HCV and Covid-19 liver involvement.
• Discuss current new developments and treatment of liver cancer – an emerging epidemic.

Topics:
• Chronic Liver Disease – Updates
• Fatty Liver and Nutrition – What is New?
• Hepatitis – Old and New
• Liver Cancer – New Options in Management